Top holdings
Name
Weight
5.25 %
4.86 %
4.77 %
3.95 %
3.95 %
3.68 %
3.56 %
3.39 %
3.00 %
2.89 %
2.64 %
2.60 %
2.44 %
2.43 %
2.40 %
2.24 %
2.04 %
2.04 %
2.04 %
1.98 %
1.82 %
1.80 %
1.76 %
1.59 %
1.49 %
1.44 %
1.44 %
1.43 %
1.41 %
1.37 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Technical Analysis
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Top holdings
Name
Weight
5.25 %
4.86 %
4.77 %
3.95 %
3.95 %
3.68 %
3.56 %
3.39 %
3.00 %
2.89 %
2.64 %
2.60 %
2.44 %
2.43 %
2.40 %
2.24 %
2.04 %
2.04 %
2.04 %
1.98 %
1.82 %
1.80 %
1.76 %
1.59 %
1.49 %
1.44 %
1.44 %
1.43 %
1.41 %
1.37 %
Analyst ratings
FAQ
- What is HELX?
- Does HELX pay dividends?
- What stocks are in HELX?
- What is the current assets under management for HELX?
- What is HELX average volume?
- What is HELX expense ratio?
- What is HELX inception date?
What is HELX?
The HELX ETF is an exchange-traded fund that focuses on companies involved in healthcare and biotechnology. It aims to provide investors with exposure to innovative healthcare solutions and advancements, offering potential growth opportunities in the rapidly evolving health sector.
Does HELX pay dividends?
Yes, the Franklin Genomic Advancements ETF does pays dividends, with
the most recent payment being
$0.00
per share. The last ex-dividend date was on December 30, 2021, and the next ex-dividend date has not been announced yet
What stocks are in HELX?
As of today, Franklin Genomic Advancements ETF inlcudes 73 holdings, with 54 of them being companies from 7 different countries and 3 sectors. The most weighted holdings are Natera (5.25%), Krystal Biotech (4.86%) and Vertex Pharmaceuticals Incorporated (4.77%)
What is the current assets under management for HELX?
Assets under management of Franklin Genomic Advancements ETF is $10 M
What is HELX average volume?
Average volume of Franklin Genomic Advancements ETF is $2512
What is HELX expense ratio?
Expense ratio of Franklin Genomic Advancements ETF is 0.50%
What is HELX inception date?
Inception date of Franklin Genomic Advancements ETF is February 27, 2020